Literature DB >> 2157668

In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B.

J E Wolf1, S E Massof.   

Abstract

Alterations in macrophage oxidative burst activity following in vivo administration of recombinant murine gamma interferon (IFN-gamma), recombinant murine tumor necrosis factor alpha, and the antifungal antibiotic amphotericin B were investigated. Mice were given intraperitoneal injections of these agents alone and in combination, and the oxidative responses of their resident peritoneal macrophages to challenge with Histoplasma capsulatum or zymosan particles were measured 1 to 5 days later. Various degrees of enhanced oxidative burst activity were achieved following treatment with each agent. However, a synergistic response was observed only when mice were treated with the combination of recombinant murine IFN-gamma and amphotericin B. These results not only confirm the dual role of amphotericin as an antifungal agent and as an immunomodulator but also suggest that IFN-gamma may serve as a useful adjunct in the treatment of intracellular fungal infections.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157668      PMCID: PMC258623          DOI: 10.1128/iai.58.5.1296-1300.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Effects of Histoplasma capsulatum on murine macrophage functions: inhibition of macrophage priming, oxidative burst, and antifungal activities.

Authors:  J E Wolf; A L Abegg; S J Travis; G S Kobayashi; J R Little
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

2.  Tumor necrosis factor-alpha and tumor necrosis factor-beta (lymphotoxin) stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo.

Authors:  K Kaushansky; V C Broudy; J M Harlan; J W Adamson
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

Review 3.  Fungal sterols and the mode of action of the polyene antibiotics.

Authors:  J M Hamilton-Miller
Journal:  Adv Appl Microbiol       Date:  1974       Impact factor: 5.086

4.  Amphotericin B induces tumor necrosis factor production by murine macrophages.

Authors:  J K Chia; M Pollack
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

5.  Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism.

Authors:  J Patterson-Delafield; R J Martinez; R I Lehrer
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

6.  Cytokine activation of murine macrophages for in vitro killing of Entamoeba histolytica trophozoites.

Authors:  M Denis; K Chadee
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

7.  Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans.

Authors:  I E Flesch; G Schwamberger; S H Kaufmann
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

8.  Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing.

Authors:  J L Pace; S W Russell; B A Torres; H M Johnson; P W Gray
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

9.  Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide.

Authors:  M J Pabst; R B Johnston
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

10.  Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation.

Authors:  H W Murray; Z A Cohn
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  29 in total

1.  Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B.

Authors:  N Mozaffarian; J W Berman; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  The mechanism of poly I:C-induced antiviral activity in peritoneal macrophage.

Authors:  S Pyo
Journal:  Arch Pharm Res       Date:  1994-04       Impact factor: 4.946

3.  Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection.

Authors:  Michael A Pammit; Varija N Budhavarapu; Erin K Raulie; Karl E Klose; Judy M Teale; Bernard P Arulanandam
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

4.  Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone).

Authors:  G W Sullivan; H T Carper; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

5.  Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum.

Authors:  P Zhou; M C Sieve; R P Tewari; R A Seder
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

6.  Reduction of no synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers.

Authors:  M Larabi; P Legrand; M Appel; S Gil; M Lepoivre; J Devissaguet; F Puisieux; G Barratt
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

7.  Effect of amphotericin B on capsule and cell size in Cryptococcus neoformans during murine infection.

Authors:  Oscar Zaragoza; Coralia Mihu; Arturo Casadevall; Joshua D Nosanchuk
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

8.  Anticryptococcal effect of amphotericin B is mediated through macrophage production of nitric oxide.

Authors:  M Tohyama; K Kawakami; A Saito
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

9.  Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.

Authors:  J Mukherjee; L S Zuckier; M D Scharff; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

10.  Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats.

Authors:  R M Fielding; P C Smith; L H Wang; J Porter; L S Guo
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.